EGFR/ErbB-2 inhibitor-1

CAS No. 1135150-79-6

EGFR/ErbB-2 inhibitor-1( —— )

Catalog No. M37253 CAS No. 1135150-79-6

EGFR/ErbB-2 inhibitor-1 is a selective ErbB2/HER2 inhibitor that effectively blocks ErbB2 and HER2 signaling.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 459 Get Quote
10MG 657 Get Quote
25MG 994 Get Quote
50MG 1371 Get Quote
100MG 1773 Get Quote
500MG 3537 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    EGFR/ErbB-2 inhibitor-1
  • Note
    Research use only, not for human use.
  • Brief Description
    EGFR/ErbB-2 inhibitor-1 is a selective ErbB2/HER2 inhibitor that effectively blocks ErbB2 and HER2 signaling.
  • Description
    EGFR/ErbB-2 inhibitor-1 is a ErbB2/HER2 inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1135150-79-6
  • Formula Weight
    467.97
  • Molecular Formula
    C23H15ClFN3OS2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    FC1=CC=CC(=C1)COC2=CC=C(C=C2Cl)NC=3N=CN=C4SC(=CC43)C=5SC=CC5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Rheault TR, et al. Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors. Bioorg Med Chem Lett. 2009 Feb 1;19(3):817-20.?
molnova catalog
related products
  • GSK-LSD1 dihydrochlo...

    GSK-LSD1 2HCl is a specificity irreversible LSD1 inhibitor (IC50: 16 nM). The selectivity of GSK-LSD1 for LSD1 is >1000 fold over other closely related FAD utilizing enzymes (i.e. MAO-A, LSD2, MAO-B).

  • Theliatinib

    Theliatinib a potent and highly selective EGFR inhibitor with anti-tumor activity. Ki of 0.05 nM for wild type EGFR and IC50s of 3 and 22 nM for EGFR and EGFR T790M/L858R mutant respectively.

  • Dacomitinib hydrate

    Dacomitinib hydrate is a highly selective and second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor family of tyrosine kinases.